MASTALERZ, HAROLD,WITTMAN, MARK D.,ZIMMERMANN, KURT,SAULNIER, MARK G.,VELAPARTHI, UPENDER,VYAS, DOLATRAI M.,ZHANG, GUIFEN,JOHNSON, WALTER LEWIS,FRENNESSON, DAVID B.,SANG, XIAOPENG,LIU, PEIYING,LANGLEY
申请号:
CA2657594
公开号:
CA2657594C
申请日:
2007.07.03
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
The invention provides compounds of formula I [INSERT CHEMICAL STRUCTURE HERE] (I) and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.